Erythema dyschromicum perstans and hepatitis C virus infection.
Kontochristopoulos
G J
GJ
Second Department of Dermatology, A Syngros Hospital, Athens, Greece.
Aroni
K
K
Anagnostopoulos
G
G
Nakopoulou
L
L
Tassopoulos
N C
NC
D000998:Antiviral Agents / Q000627:therapeutic use; D004890:Erythema / Q000150:complications* / Q000473:pathology; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000150:complications* / Q000473:pathology; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin